Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 4
2000 6
2001 7
2002 12
2003 13
2004 21
2005 26
2006 21
2007 31
2008 31
2009 38
2010 46
2011 54
2012 38
2013 48
2014 29
2015 53
2016 60
2017 30
2018 32
2019 36
2020 37
Text availability
Article attribute
Article type
Publication date

Search Results

603 results
Results by year
Filters applied: . Clear all
Page 1
The PI3K/AKT pathway in the pathogenesis of prostate cancer.
Chen H, Zhou L, Wu X, Li R, Wen J, Sha J, Wen X. Chen H, et al. Front Biosci (Landmark Ed). 2016 Jun 1;21:1084-91. doi: 10.2741/4443. Front Biosci (Landmark Ed). 2016. PMID: 27100493 Review.
Inflammatory cytokines (CCR9, IL-6, and TLR3) regulate PI3K/AKT signaling during apoptosis of PCa cells, and PI3K/AKT signaling participates with androgen-, 1alpha,25(OH)2-vitamin D3-, and prostaglandin-associated mechanisms and is regulated by ErbB, EGFR, and the HER fami …
Inflammatory cytokines (CCR9, IL-6, and TLR3) regulate PI3K/AKT signaling during apoptosis of PCa cells, and PI3K/AKT signaling parti …
Mucosal Chemokines.
Hernández-Ruiz M, Zlotnik A. Hernández-Ruiz M, et al. J Interferon Cytokine Res. 2017 Feb;37(2):62-70. doi: 10.1089/jir.2016.0076. J Interferon Cytokine Res. 2017. PMID: 28207301 Free PMC article. Review.
CCL25 recruits certain important subsets of T cells that express CCR9 to the small intestine. These CCR9(+) T cells also express the integrin α4β7 and have been shown to play important roles in the control of intestinal inflammation. ...
CCL25 recruits certain important subsets of T cells that express CCR9 to the small intestine. These CCR9(+) T cells also expre …
Structural Analysis of Chemokine Receptor-Ligand Interactions.
Arimont M, Sun SL, Leurs R, Smit M, de Esch IJP, de Graaf C. Arimont M, et al. J Med Chem. 2017 Jun 22;60(12):4735-4779. doi: 10.1021/acs.jmedchem.6b01309. Epub 2017 Mar 10. J Med Chem. 2017. PMID: 28165741 Free PMC article. Review.
A comparative analysis of ligand binding pockets in chemokine receptors is presented, including a detailed description of the CXCR4, CCR2, CCR5, CCR9, and US28 X-ray structures, and their implication for modeling molecular interactions of chemokine receptors with small-mol …
A comparative analysis of ligand binding pockets in chemokine receptors is presented, including a detailed description of the CXCR4, CCR2, C …
Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise.
Trivedi PJ, Adams DH. Trivedi PJ, et al. J Crohns Colitis. 2018 Aug 22;12(suppl_2):S641-S652. doi: 10.1093/ecco-jcc/jjx145. J Crohns Colitis. 2018. PMID: 30137309 Free PMC article. Review.
The principal targets for anti-chemokine therapy in inflammatory bowel disease (IBD) have been the receptors CCR9 and CXCR3 and their respective ligands CCL25 and CXCL10. ...
The principal targets for anti-chemokine therapy in inflammatory bowel disease (IBD) have been the receptors CCR9 and CXCR3 and their …
Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis.
Kadowaki A, Saga R, Lin Y, Sato W, Yamamura T. Kadowaki A, et al. Brain. 2019 Apr 1;142(4):916-931. doi: 10.1093/brain/awz012. Brain. 2019. PMID: 30770703 Free PMC article.
The reduction in the proportion of CCR9+ cells among CD4+ memory T cells (%CCR9) in SPMS did not correlate with age, disease duration or expanded disability status scale score, although %CCR9 decreased linearly with age in healthy controls. ...The evaluation …
The reduction in the proportion of CCR9+ cells among CD4+ memory T cells (%CCR9) in SPMS did not correlate with age, disease d …
Interfering with leukocyte trafficking in Crohn's disease.
Biswas S, Bryant RV, Travis S. Biswas S, et al. Best Pract Res Clin Gastroenterol. 2019 Feb-Apr;38-39:101617. doi: 10.1016/j.bpg.2019.05.004. Epub 2019 May 28. Best Pract Res Clin Gastroenterol. 2019. PMID: 31327399 Review.
Targets for modulators of leukocyte trafficking include (examples in brackets) ICAM-1 (alicaforsen, efalizumab); MAdCAM-1 (PF-00547 659); α4 and related receptors (abrilumab, etrolizumab, natalizumab, vedolizumab); chemokine receptor CCR9 (vercirnon); and sphingosine 1-pho …
Targets for modulators of leukocyte trafficking include (examples in brackets) ICAM-1 (alicaforsen, efalizumab); MAdCAM-1 (PF-00547 659); α4 …
Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
Blokland SLM, Kislat A, Homey B, Smithson GM, Kruize AA, Radstake TRDJ, van Roon JAG. Blokland SLM, et al. Scand J Immunol. 2020 Mar;91(3):e12852. doi: 10.1111/sji.12852. Epub 2019 Dec 13. Scand J Immunol. 2020. PMID: 31733111 Free PMC article.
Our aim was to study co-expression of chemokine receptors on CCR9 + Th cells and whether in pSS this might differentially affect CCR9 + Th cell frequencies. Frequencies of circulating CCR9 + and CCR9- Th cells co-expressing CXCR3, CCR4, CCR6 and CCR10 …
Our aim was to study co-expression of chemokine receptors on CCR9 + Th cells and whether in pSS this might differentially affect C
Cow's Milk and Immune Function in the Respiratory Tract: Potential Mechanisms.
Perdijk O, van Splunter M, Savelkoul HFJ, Brugman S, van Neerven RJJ. Perdijk O, et al. Front Immunol. 2018 Feb 12;9:143. doi: 10.3389/fimmu.2018.00143. eCollection 2018. Front Immunol. 2018. PMID: 29483908 Free PMC article. Review.
Expression of the tissue homing-associated markers α4β7 and CCR9 or CCR10 on lymphocytes can be influenced by vitamin A and vitamin D3, respectively. ...
Expression of the tissue homing-associated markers α4β7 and CCR9 or CCR10 on lymphocytes can be influenced by vitamin A and vitamin D …
[Treatment for rheumatoid arthritis by chemokine blockade].
Nanki T. Nanki T. Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(3):172-80. doi: 10.2177/jsci.39.172. Nihon Rinsho Meneki Gakkai Kaishi. 2016. PMID: 27320932 Free article. Review. Japanese.
Blockade of CCL2, CCL3, CCL5, CCR1, CCR9, CXCL2, CXCL5, CXCL13, CXCL16, CXCR3, CXCR4, CXCR7, and CX3CL1 showed improvement of arthritis of animal models. ...
Blockade of CCL2, CCL3, CCL5, CCR1, CCR9, CXCL2, CXCL5, CXCL13, CXCL16, CXCR3, CXCR4, CXCR7, and CX3CL1 showed improvement of arthrit …
Interleukin-6-mediated CCR9(+) interleukin-17-producing regulatory T cells polarization increases the severity of necrotizing enterocolitis.
Ma F, Li S, Gao X, Zhou J, Zhu X, Wang D, Cai Y, Li F, Yang Q, Gu X, Ge W, Liu H, Xiao X, Hao H. Ma F, et al. EBioMedicine. 2019 Jun;44:71-85. doi: 10.1016/j.ebiom.2019.05.042. Epub 2019 May 23. EBioMedicine. 2019. PMID: 31129099 Free PMC article.
Elevated CCR9(+) CD4(+) T cells were primarily CCR9(+) IL-17-producing Treg cells, possessing features of conventional Treg cells, but their suppressive activity was seriously impaired and negatively correlated with the severity of intestinal tissue injury. IL-6 pro …
Elevated CCR9(+) CD4(+) T cells were primarily CCR9(+) IL-17-producing Treg cells, possessing features of conventional Treg ce …
603 results
Jump to page
Feedback